$700.55
-3.65-0.52%
At close: Dec 12, 4:00 PM EST
$700.55
N/A
Pre-Market: 8:54 AM EST
IDEXX Laboratories issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
The most recent guidance for IDEXX Laboratories (IDXX) was reported on November 3, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $12.81 to $13.01, compared to the estimated EPS of $12.62. Additionally, IDEXX Laboratories forecasted revenue between $4.27B and $4.30B for the quarter.
Browse guidance and forecast on all stocks.